Dr Emil Jay Vancura, MD in Riverside, IL - Preventive Medicine

Dr Emil Jay Vancura, MD is a Preventive Medicine - Occupational Medicine physician based in Riverside, Illinois. Dr Emil Jay Vancura is licensed to practice in Illinois (license number ) and his current practice location is 181 Scottswood Rd, Riverside, Illinois. He can be reached at his office (for appointments etc.) via phone at (708) 447-6500.

NPI number for Dr Emil Jay Vancura is 1013123769 and his current mailing address is 181 Scottswood Rd, Riverside, Illinois. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1013123769.

Contact Information

	Dr Emil Jay Vancura, MD
	181 Scottswood Rd, Riverside, IL 60546-2221
	(708) 447-6500
	(708) 447-6500

Physician's Profile

Full Name	Dr Emil Jay Vancura
Gender	Male
Speciality	Preventive Medicine - Occupational Medicine
Location	181 Scottswood Rd, Riverside, Illinois
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1013123769
Provider Enumeration Date: 05/16/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr Emil Jay Vancura such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1013123769	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2083X0100X	Preventive Medicine - Occupational Medicine	(Illinois)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Emil Jay Vancura is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Emil Jay Vancura, MD 181 Scottswood Rd, Riverside, IL 60546-2221 Ph: (708) 447-6500	Dr Emil Jay Vancura, MD 181 Scottswood Rd, Riverside, IL 60546-2221 Ph: (708) 447-6500

News Archive

Brooklyn woman infected with West Nile virus

According to health officials in New York a 41-year-old woman from Brooklyn has become the year's first known human case of the West Nile virus in New York State.

Allegro receives FDA IND approval to initiate Phase II clinical studies of ALG-1001 in AMD, VMT patients

Allegro Ophthalmics, LLC, a company dedicated to establishing Integrin Peptide Therapy as the next-generation pharmaceutical category for the treatment of vascular eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to begin two Phase II clinical studies of ALG-1001.

New cystic fibrosis drug now available through NHS England

On October 24, 2019, cystic fibrosis (CF) patients rejoiced at the news that three years of talks between the UK's National Institute for Health and Care Excellence (NICE) and Vertex Pharmaceuticals had succeeded in a compromise which could see about 5,000 patients gaining access to a potentially life-saving drug called Orkambi within the next month. Orkambi is perceived to be a ‘wonder drug' because it helps these patients to breathe easier and better, and can be started as young as two years.

Scientists identify two potential new drug targets for treatment of HIV

Johns Hopkins scientists report they have identified two potential new drug targets for the treatment of HIV. The finding is from results of a small, preliminary study of 19 people infected with both HIV-;the virus that causes AIDS-;and the hepatitis C virus.

Dr Emil Jay Vancura, MD - Preventive Medicine in Riverside, IL